J. Spaide

431 total citations
21 papers, 303 citations indexed

About

J. Spaide is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Physiology. According to data from OpenAlex, J. Spaide has authored 21 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biological Psychiatry, 10 papers in Psychiatry and Mental health and 7 papers in Physiology. Recurrent topics in J. Spaide's work include Tryptophan and brain disorders (11 papers), Diet and metabolism studies (7 papers) and Schizophrenia research and treatment (6 papers). J. Spaide is often cited by papers focused on Tryptophan and brain disorders (11 papers), Diet and metabolism studies (7 papers) and Schizophrenia research and treatment (6 papers). J. Spaide collaborates with scholars based in United States and Japan. J. Spaide's co-authors include Harold E. Himwich, N. Narasimhachari, H. H. Berlet, B Heller, G.R. Pscheidt, Maiko Fujimori, Herbert Y. Meltzer, Jaime Bueno, Herbert H. Kohl and Kunio Matsumoto and has published in prestigious journals such as Nature, Science and American Journal of Psychiatry.

In The Last Decade

J. Spaide

21 papers receiving 220 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Spaide United States	12	82	77	69	61	55	21	303
B Heller Argentina	10	136 1.7×	46 0.6×	87 1.3×	55 0.9×	46 0.8×	19	334
Elnora Van Winkle United States	8	60 0.7×	24 0.3×	71 1.0×	88 1.4×	46 0.8×	9	364
Jerry Oliver United States	10	135 1.6×	45 0.6×	77 1.1×	136 2.2×	50 0.9×	13	453
Harry Freeman United States	12	103 1.3×	45 0.6×	67 1.0×	137 2.2×	19 0.3×	34	432
E. Fischer Argentina	10	112 1.4×	24 0.3×	58 0.8×	36 0.6×	27 0.5×	31	267
Izyaslav P. Lapin Russia	11	159 1.9×	30 0.4×	121 1.8×	53 0.9×	107 1.9×	16	438
Charles E. Frohman United States	13	55 0.7×	32 0.4×	144 2.1×	114 1.9×	43 0.8×	36	588
E Rothlin Japan	12	148 1.8×	147 1.9×	94 1.4×	38 0.6×	8 0.1×	49	541
A. C. Tait United Kingdom	9	141 1.7×	31 0.4×	111 1.6×	119 2.0×	26 0.5×	10	423
J Delay France	7	77 0.9×	51 0.7×	52 0.8×	135 2.2×	22 0.4×	20	309

Countries citing papers authored by J. Spaide

Since Specialization

Citations

This map shows the geographic impact of J. Spaide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Spaide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Spaide more than expected).

Fields of papers citing papers by J. Spaide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Spaide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Spaide. The network helps show where J. Spaide may publish in the future.

Co-authorship network of co-authors of J. Spaide

This figure shows the co-authorship network connecting the top 25 collaborators of J. Spaide. A scholar is included among the top collaborators of J. Spaide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Spaide. J. Spaide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spaide, J., et al.. (1972). Effects of tranylcypromine andl-cysteine on plasma amino acids in controls and schizophrenic patients. American Journal of Clinical Nutrition. 25(3). 302–310. 6 indexed citations

Narasimhachari, N., et al.. (1971). Urinary studies of schizophrenics and controls.. PubMed. 3(1). 9–20. 40 indexed citations

Spaide, J., et al.. (1971). An evaluation of various survival rations. American Journal of Clinical Nutrition. 24(5). 513–523. 2 indexed citations

Spaide, J., et al.. (1971). Plasma amino acids in schizophrenic patients with methionine or cysteine loading and a monoamine oxidase inhibitor. American Journal of Clinical Nutrition. 24(9). 1053–1059. 2 indexed citations

Narasimhachari, N., et al.. (1971). N,N-dimethylated indoleamines in blood.. PubMed. 3(1). 21–3. 40 indexed citations

Spaide, J., et al.. (1970). Detection of Psychotomimetic N,N-Dimethylated Indoleamines in the Urine of Four Schizophrenic Patients. The British Journal of Psychiatry. 117(539). 421–430. 31 indexed citations

Heller, B, et al.. (1970). N-dimethylated indoleamines in blood of acute schizophrenics. Cellular and Molecular Life Sciences. 26(5). 503–504. 25 indexed citations

Narasimhachari, N., et al.. (1970). Comparative behavioral and biochemical effects of tranylcypromine and cysteine on normal controls and schizophrenic patients. Life Sciences. 9(18). 1021–1032. 11 indexed citations

Spaide, J., et al.. (1969). Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.. PubMed. 1(3). 227–33. 8 indexed citations

10.

Spaide, J., et al.. (1968). Psychotogenic N,N-Dimethylated Indole Amines and Behavior in Schizophrenic Patients. PubMed. 10. 6–15. 4 indexed citations

11.

Spaide, J.. (1968). Behavioral and Biochemical Alterations in Schizophrenic Patients. Archives of General Psychiatry. 18(6). 658–658. 16 indexed citations

12.

Spaide, J., et al.. (1967). Psychotomimetic Indole Compound in the Urine of Schizophrenics and Mentally Defective Patients. Nature. 216(5114). 490–491. 18 indexed citations

13.

Spaide, J., et al.. (1967). Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine). Life Sciences. 6(5). 551–560. 9 indexed citations

14.

Spaide, J., et al.. (1967). Occurrence of bufotenin (5-hydroxy-N, N-dimethyltryptamine) in urine of schizophrenic patients. Life Sciences. 6(16). 1697–1706. 14 indexed citations

15.

Berlet, H. H., et al.. (1966). Variations of urinary creatinine and its correlation to excretion of indole metabolites in mental patients. Clinica Chimica Acta. 13(2). 228–234. 15 indexed citations

16.

Berlet, H. H., et al.. (1965). EFFECTS OF REDUCTION OF TRYPTOPHAN AND METHIONINE INTAKE ON URINARY INDOLE COMPOUNDS AND SCHIZOPHRENIC BEHAVIOR. The Journal of Nervous and Mental Disease. 140(4). 297–304. 4 indexed citations

17.

Pscheidt, G.R., et al.. (1964). Excretion of catecholamines and exacerbation of symptoms in schizophrenic patients. Journal of Psychiatric Research. 2(3). 163–168. 15 indexed citations

18.

Berlet, H. H., Harold E. Himwich, Herbert H. Kohl, et al.. (1964). Endogenous Metabolic Factor in Schizophrenic Behavior. Science. 144(3616). 311–313. 20 indexed citations

19.

Berlet, H. H., G.R. Pscheidt, J. Spaide, & Harold E. Himwich. (1964). Variations of Urinary Creatinine and its Correlation to Tryptamine Excretion in Schizophrenic Patients. Nature. 203(4950). 1198–1199. 15 indexed citations

20.

Berlet, H. H., et al.. (1963). Effect of diet on schizophrenic behavior. Comprehensive Psychiatry. 4(6). 483–484. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact